Ignite Creation Date:
2025-12-24 @ 9:22 PM
Ignite Modification Date:
2025-12-25 @ 7:09 PM
Study NCT ID:
NCT01462604
Status:
COMPLETED
Last Update Posted:
2018-06-19
First Post:
2011-09-21
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Pilot Study of Patient's Adherence to TYKERB™/TYVERB™ + Capecitabine in Metastatic Breast Cancer
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-11-23
Start Date Type:
None
Primary Completion Date:
2013-01-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-01-24
Completion Date Type:
ACTUAL
First Submit Date:
2011-09-21
First Submit QC Date:
None
Study First Post Date:
2011-10-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-06-18
Last Update Post Date:
2018-06-19
Last Update Post Date Type:
ACTUAL